Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Marseille
SEC filing record 1 source field available
Fiscal year end
31 December
Innate Pharma SA has filed 337 SEC EDGAR filings since 31 Jan 2014

SEC filing history

Showing 226-250 of 337 matching filings.

Per page
25
Current page
10
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
15 Feb 2022
Reporting date
15 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
04 Feb 2022
Reporting date
04 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. FORM 6-K

Filing date
24 Jan 2022
Reporting date
24 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
05 Jan 2022
Reporting date
05 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
04 Jan 2022
Reporting date
04 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
16 Dec 2021
Reporting date
16 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. FORM 6-K

Filing date
09 Dec 2021
Reporting date
09 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
02 Dec 2021
Reporting date
02 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
24 Nov 2021
Reporting date
24 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. FORM 6-K

Filing date
16 Nov 2021
Reporting date
16 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
12 Nov 2021
Reporting date
12 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
09 Nov 2021
Reporting date
09 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
26 Oct 2021
Reporting date
26 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
15 Oct 2021
Reporting date
15 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

FORM 6-K

Filing date
23 Sep 2021
Reporting date
23 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

FORM 6-K

Filing date
17 Sep 2021
Reporting date
17 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

FORM 6-K

Filing date
07 Sep 2021
Reporting date
07 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

FORM 6-K

Filing date
02 Sep 2021
Reporting date
02 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

FORM 6-K

Filing date
30 Aug 2021
Reporting date
30 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

FORM 6-K

Filing date
11 Aug 2021
Reporting date
11 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-257834

S-8

Filing date
12 Jul 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

FORM 6-K

Filing date
12 Jul 2021
Reporting date
12 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

FORM 6-K

Filing date
06 Jul 2021
Reporting date
06 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

FORM 6-K

Filing date
22 Jun 2021
Reporting date
22 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .